Monitoring therapy

British Journal of Clinical Pharmacology

Volumn 60, Issue 3, 2005, Pages 229-230

  Aronson, J K ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ATAZANAVIR; CYTOTOXIC AGENT; DIGOXIN; INDINAVIR; LITHIUM; NELFINAVIR; PHENYTOIN; THEOPHYLLINE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL PROTOCOL; DRUG MONITORING; EDITORIAL; HISTORY OF MEDICINE; HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PUBLICATION;

ADULT; DRUG MONITORING; FEMALE; HUMANS; MALE; MONITORING, PHYSIOLOGIC;

EID: 24044443584     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2005.02490.x     Document Type: Editorial

References (19)

1. Aronson JK. An Account of the Foxglove and its Medical Uses 1785-1985. Oxford: Oxford University Press, 1985: 40-3.
2. Aronson JK. Biomarkers and surrogate endpoints. Br J Clin Pharmacol 2005; 59: 491-4.
3. Shenfield GM, ed. Therapeutic drug monitoring. Br J Clin Pharmacol 2001; 52(Suppl 1).
4. Noack CH, Trautner EM. The lithium treatment of maniacal psychosis. Med J Aust 1951; 2: 219-22.
5. Brodie BB, Reid WD. The value of determining the plasma concentration of drugs in animals and man. In: La Du BN, Mandel HG, Way EL, eds. Fundamentals of Drug Metabolism and Drug Disposition. Baltimore: Williams and Wilkins Company, 1971: 328-39.
6. Evenson MA. Developments in therapeutic drug monitoring and alkaloid analysis. Fed Proc 1975; 34: 2131-3.
7. Campbell TJ, Williams KM. Therapeutic drug monitoring: antiarrhythmic drugs. Br J Clin Pharmacol 2001; 52(Suppl 1): 21S-34S.
8. Eadie MJ. Therapeutic drug monitoring - antiepileptic drugs. Br J Clin Pharmacol 2001; 52(Suppl 1): 11S-20S.
9. Mitchell PB. Therapeutic drug monitoring of psychotropic medications. Br J Clin Pharmacol 2001; 52(Suppl 1): 45S-54S.
10. Begg EJ, Barclay ML, Kirkpatrick CM. The therapeutic monitoring of antimicrobial agents. Br J Clin Pharmacol 2001; 52(Suppl 1): 35S-43S.
11. Aronson JK, Hardman M, Reynolds DJM. ABC of Monitoring Drug Therapy. London: BMJ Publishing Group, 1993: 21-4.
12. Johnston A, Holt DW. Immunosuppressant drugs - the role of therapeutic drug monitoring. Br J Clin Pharmacol 2001; 52(Suppl 1): 61S-73S.
13. Lennard L. Therapeutic drug monitoring of cytotoxic drugs. Br J Clin Pharmacol 2001; 52(Suppl 1): 75S-87S.
14. Back DJ, Khoo SH, Gibbons SE, Merry C. The role of therapeutic drug monitoring in treatment of HIV infection. Br J Clin Pharmacol 2001; 52(Suppl 1): 89S-96S.
15. Ray JE, Marriott D, Bloch MT, Mclachlan AJ. Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic. Br J Clin Pharmacol 2005; 60: 291-9.
16. Burger D, Hugen P, Reiss P, Gyssens I, Schneider M, Kroon F, Schreij G, Brinkman K, Richter C, Prins J, Aarnoutse R, Lange J, Athena Cohort Study Group. Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals. AIDS 2003; 17: 1157-65.
17. Jannuzzi G, Cian P, Fattore C, Gatti G, Bartoli A, Monaco F, Perucca E. A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group Epilepsy. Epilepsia 2000; 41: 222-30.
18. Glasziou P, Irwig L, Mant D. Monitoring in chronic disease: a rational approach. Br Med J 2005; 330: 644-8.
19. Pirmohamed M, Ferner RE. Monitoring drug treatment. Br Med J 2003; 327: 1179-81.